SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001585364-24-000126
Filing Date
2024-09-10
Accepted
2024-09-10 15:29:43
Documents
3
Period of Report
2024-09-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1725996575.html 4  
1 FORM 4 wk-form4_1725996575.xml 4 4660
2 EX-24 poa-davidballdocx.htm EX-24 3154
3 GRAPHIC poa-davidballdocx001.jpg GRAPHIC 211670
  Complete submission text file 0001585364-24-000126.txt   300977
Mailing Address 515 EASTERN AVENUE ALLEGAN MI 49010
Business Address THE SHARP BUILDING HOGAN PLACE DUBLIN 2 L2 D02 TY74 269-673-8451
PERRIGO Co plc (Issuer) CIK: 0001585364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PERRIGO COMPANY PLC 430 MONROE AVE NW GRAND RAPIDS MI 49503
Business Address
Ball David (Reporting) CIK: 0002034010 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36353 | Film No.: 241289914